AO GENERIUM Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Moscow Russian Federation (2009)

Organization Overview

First Clinical Trial
2017
NCT04601389
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AO GENERIUM